Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma

Código QR

Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma

Guardado en:

Detalles Bibliográficos
Autores principales:	Thomas F Gajewski, Ken Hatogai, Robin Reschke, Jovian Yu, Emily F Higgs, Blake A Flood
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/f9e279c1b9724561b39c21d3d4952698
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Correction: Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Publicado: (2021)

Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12
por: Brile Chung, et al.
Publicado: (2017)

FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy
por: A. Flaus, et al.
Publicado: (2021)

Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells
por: Jiajun Du, et al.
Publicado: (2020)

Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria
por: Isabella C. Hirako, et al.
Publicado: (2016)

A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.
por: Alexandre Hainard, et al.
Publicado: (2009)

Nanotechnology-enhanced immunotherapy for metastatic cancer
por: Peisen Zhang, et al.
Publicado: (2021)

Treatment of Advanced Metastatic Melanoma
por: Pietro Quaglino, et al.
Publicado: (2021)

DYNAMIC CHANGES OF CHEMOKINE CXCL-10 (IP-10) IN CHILDREN AND ADOLESCENTS WITH DIFFERENT FORMS OF PULMONARY TUBERCULOSIS
por: M. M. Averbakh (Jr), et al.
Publicado: (2016)

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
por: Lieve Brochez, et al.
Publicado: (2018)

CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner
por: Pil Soo Sung, et al.
Publicado: (2017)

Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [<sup>18</sup>F]FDG PET/CT in Metastatic Melanomas and Lung Cancer
por: Egesta Lopci
Publicado: (2021)

B cell zone reticular cell microenvironments shape CXCL13 gradient formation
por: Jason Cosgrove, et al.
Publicado: (2020)

Microenvironment-derived factors driving metastatic plasticity in melanoma
por: Isabella S. Kim, et al.
Publicado: (2017)

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast
por: Milim Kim, et al.
Publicado: (2021)

Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling
por: Hye-Youn Kim, et al.
Publicado: (2017)

Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma
por: Natalia Kułach, et al.
Publicado: (2021)

Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
por: Jason B. Williams, et al.
Publicado: (2020)

Reply to ‘Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma’
por: Nicolas Jacquelot, et al.
Publicado: (2018)

Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma
por: Min Yan, et al.
Publicado: (2021)

Multiregional genetic evolution of metastatic uveal melanoma
por: Daniel A. Rodriguez, et al.
Publicado: (2021)

A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells
por: Zijun Wang, et al.
Publicado: (2021)

A Lipidomic Approach to Identify Potential Biomarkers in Exosomes From Melanoma Cells With Different Metastatic Potential
por: Simona Lobasso, et al.
Publicado: (2021)

SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
por: Yu. A. Khochenkova, et al.
Publicado: (2014)

Spontaneous Regression of Primary Melanoma and Multiple Melanocytic Nevi in a Patient With Metastatic Melanoma
por: Giovanni Paolino, et al.
Publicado: (2020)

Molecular profiling of driver events in metastatic uveal melanoma
por: Joakim Karlsson, et al.
Publicado: (2020)

Metastatic melanoma to the ovary in pregnancy: A case report
por: D.S. Huang, et al.
Publicado: (2021)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Ryota Tanaka, et al.
Publicado: (2021)

Proton NMR characterization of intact primary and metastatic melanoma cells in 2D & 3D cultures
por: Ramachandran,Gokula Krishnan, et al.
Publicado: (2017)

Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10
por: Weiyuan Li, et al.
Publicado: (2021)

The effects of T-DXd on the expression of HLA class I and chemokines CXCL9/10/11 in HER2-overexpressing gastric cancer cells
por: Shotaro Nakajima, et al.
Publicado: (2021)

miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma
por: Mai-Huong Thi Nguyen, et al.
Publicado: (2021)

Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
por: David J. Benjamin, et al.
Publicado: (2021)

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
por: Tingting Wang, et al.
Publicado: (2018)

CXCL12 and [N33A]CXCL12 in 5637 and HeLa cells: regulating HER1 phosphorylation via calmodulin/calcineurin.
por: Antonella Rigo, et al.
Publicado: (2012)

CXCL13 Is an Indicator of Germinal Center Activity and Alloantibody Formation Following Transplantation
por: Emma S. Crichton, MD, MPH, et al.
Publicado: (2021)

L-Tyrosine-loaded nanoparticles increase the antitumoral activity of direct electric current in a metastatic melanoma cell model
por: V&acirc;nia Emerich Bucco de Campos, et al.
Publicado: (2010)

Metastatic and non-metastatic melanoma imaging using Sgc8-c aptamer PTK7-recognizer
por: Estefanía Sicco, et al.
Publicado: (2021)

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Mizue Terai, et al.
Publicado: (2021)

The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
por: Jan Pals, et al.
Publicado: (2021)